Porton Advanced
About Us
About Porton
Contact Us
Careers
Track Records
Research & Preclinical
Vector Construction & Plasmid Service
Pre-Made & Custom made Vectors
AAVantage Novel AAV Capsid Library Platform
Gene with Genome
Off-the-shelf Product
CDMO Solutions
Cell Engineering CMC services
Plasmid
Lentiviral Vector
Adeno Associated Virus
mRNA
Platforms
Innovative Services
Investigator-Initiated Clinical Trial
Pipeline Licensing Service
Analytical Development and Testing
News & Insights
Publications and Whitepaper
Brochures Downloads
Scientific Blogs
Newsroom
Event
Contact Us
About Porton
Contact Us
Careers
Track Records
Vector Construction & Plasmid Service
Vector Cloning Services
Plasmid Preparation Services
Pre-Made & Custom made Vectors
Adeno-associated Viral Vector
Pre-made and Custom-made Lentiviral Vectors (LVVs)
mRNA and circRNA
AAVantage Novel AAV Capsid Library Platform
AAVantage® AAV Capsid Library Products
AI-guided AAV Library Construction and Screening
Gene with Genome
Gene Editing Strategies and Efficiency Validation
Stable Cell Line Engineering
Off-the-shelf Product
Lentivirus Helper Plasmids
Cell Engineering CMC services
Plasmid
GMP Lentivirus Helper Plasmids
Lentiviral Vector
LV-SMART™-LVVs Suspension Production Platform
Adeno Associated Virus
mRNA
Platforms
Process Development
GMP Manufacturing
Quality Systems
Analytical Development and Quality Control
Investigator-Initiated Clinical Trial
Pipeline Licensing Service
Analytical Development and Testing
Analytical Development and Testing
Functional Platforms
Testing Services
Publications and Whitepaper
Publications
Whitepaper
Brochures Downloads
Scientific Blogs
Newsroom
Collaborations
Cases
Event
Whitepaper
Publications
Whitepaper
Whitepaper
Whitepaper
| May 13, 2025
Expanding patient access to gene therapies through AAV capsid engineering
Read More
Get In Touch With
Porton Expert Team Today
I consent to receive updates on products and events from Porton, and give consent based on Porton's
Privacy Policy
.
Send Inquiry Now
Clients & Partners
View More
